Skip to main content

Table 2 Comparison of PSA, PCA3 and TMPRSS2:ERG mRNA copy levels in CTC enriched fractions from androgen-independent prostate cancer patients.

From: Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood

Patient #

PSA

PCA3

TMPRSS2: ERG

1

213,277

9,851

N/A

2

-

-

N/A

3

631

-

-

4

1,097

-

-

5

-

312

-

6

-

-

-

7

658

-

-

8

13,294

-

+

9

189,634

546

-

10

10,088

4,478

-

11

208,727

-

+

12

-

-

-

13

-

-

-

14

-

-

-

15

6,264

261

+

16

-

-

-

  1. Blood samples from prostate cancer patients were processed using the dual antibody (anti-PSMA plus anti-EpCAM) magnetic particle formulation. CTC enriched fractions were prepared from patients diagnosed with advanced androgen-independent prostate cancer (n = 16). N/A = insufficient sample available for measurement.
Back to article page

Molecular Cancer

ISSN: 1476-4598